Renaissance Capital logo

Absci Priced, Nasdaq: ABSI

Provides a synthetic biology platform used to develop protein therapies.

Industry: Health Care

Latest Trade: $31.00 +1.71 (+5.8%)

First Day Return: +34.9%

Return from IPO: +83.1%

Industry: Health Care

Our mission is to change the world, one protein at a time. We founded Absci with the goal of creating better medicines and helping them reach patients sooner. We recognized the extraordinary medical and economic potential of protein-based drugs (biologics), but also the significant challenges the biopharmaceutical industry faces to both discover novel biologics and generate cell lines to manufacture them at commercial scale. We built our technology to be that how. We believe we are replacing the fragmented steps and inefficiencies of the conventional biologic drug discovery and cell line development processes with our fully integrated, end-to-end platform designed to create new and better biologics and accelerate their advancement into clinical trials and ultimately into the marketplace where they can serve patients. Combining innovative approaches, including synthetic biology, high-throughput single-cell screening, and deep learning artificial intelligence (AI), we seek to identify optimal drug candidates by exploring expansive protein sequence solution spaces -- including considering sequences that nature's evolutionary trajectory has yet to propose. We believe our platform allows us to expand biological possibilities and generate proteins intractable to produce with other technologies to ensure the best drug candidates have the opportunity to become therapeutic realities for patients. Our goal is to enable the creation of better medicines by Translating Ideas into Drugs.
more less
IPO News for Absci
more
IPO Data
IPO File Date 06/30/2021
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 12.5
Deal Size ($mm) $200
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/21/2021
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 12.5
Deal Size ($mm) $200
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Vancouver, WA
Founded 2011
Employees 169
Website www.absci.com